Nutcracker Therapeutics Stock
Nutcracker Therapeutics is a biotechnology company focused on advancing RNA-based treatments through innovative manufacturing technologies. Nutcracker aims to revolutionize the development of RNA therapeutics by leveraging its proprietary platform for mRNA synthesis and formulation.
Sign up for SecondMarket™ to view the market and buy or sell Nutcracker Therapeutics Stock
Buy + SellNutcracker Therapeutics Funding
Sign up to gain insights into Nutcracker Therapeutics funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Aug 27, 2021 | Series C | 144.50M | ||
| May 08, 2020 | Series B | 14.00M | ||
| Mar 11, 2019 | Series A | 10.00M | ||
| Apr 30, 2018 | Series Seed | 4.00M |
See Nutcracker Therapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Nutcracker Therapeutics Stock Valuation + Share Prices
View real-time Tape D™ data on Nutcracker Therapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Leverage Your Equity to Help Achieve More.
Nutcracker Therapeutics Management Team
Co-Founder, CEO
Igor Khandros
Director
Michael Bigham
Nutcracker Therapeutics Major Investors
ARCH Venture Partners
Bluebird Ventures
Sutter Hill Ventures
Learn More About Nutcracker Therapeutics Stock
Buy Nutcracker Therapeutics Stock
01
Nutcracker Therapeutics stock does not trade on public stock exchanges. Nutcracker Therapeutics stock is considered a private security and you need to be an accredited investor to purchase shares. To invest in Nutcracker Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Get started to begin exploring private market opportunities.
Sell Nutcracker Therapeutics Stock
02
Nutcracker Therapeutics Stock does not trade on public stock exchanges. In order to sell Nutcracker Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Get started to begin exploring private market opportunities.
Nutcracker Therapeutics Stock Price
03
Nutcracker Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Nutcracker Therapeutics share price and other valuable private market data.
Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Nutcracker Therapeutics Stock Ticker Symbol
04
There is no ticker symbol for Nutcracker Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company “street” name or legal name.
Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Criteria to Sell Nutcracker Therapeutics Stock
05
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Nutcracker Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Criteria to Buy or Invest in Nutcracker Therapeutics Stock
06
Currently, Nasdaq Private Market only works with institutional investors to purchase private company stock. In order to invest in Nutcracker Therapeutics stock you need to be an institutional investor.
Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Nutcracker Therapeutics Stock Settlement
07
Once you buy or sell stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
Nutcracker Therapeutics IPO
08
Nutcracker Therapeutics is a private company and has not had an IPO. There is currently no Nutcracker Therapeutics IPO price.
Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Nutcracker Therapeutics IPO.
Sign up for SecondMarket™ to view the market and buy or sell Nutcracker Therapeutics Stock
Buy + SellOther Companies
Source:
Nasdaq Private Market Tape D™